Market Tracker

07/29 3:38am ET

Emergent BioSolutions Inc (NYSE:EBS)

32.85
Delayed Data
As of Jul 28
 -0.93 / -2.75%
Today’s Change
27.01
Today|||52-Week Range
44.38
-17.90%
Year-to-Date

Today’s Trading

Previous close33.78
Today’s open33.68
Day’s range32.84 - 34.10
Volume448,698
Average volume (3 months)649,828
Market cap$1.4B
Dividend yield--
Data as of 4:02pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-14.18%
Earnings growth (next 5 years)+23.50%
Revenue growth (last year)+16.14%
P/E ratio18.5
Price/Sales3.62
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc-0.09-0.76%
SAGESAGE Therapeutics In...-0.33-0.73%
ACORAcorda Therapeutics ...-1.76-6.59%
DERMDermira Inc-1.22-3.55%
Data as of 3:59pm ET, 07/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts